AzTrials
AzTrials

Artificial IntelligenceNCT05497258

IDEAS-AAP System Diagnoses Acute Abdominal Pain

A study testing Artificial intelligence assistant system in people with Artificial Intelligence and Diagnoses Disease, run by Renmin Hospital of Wuhan University at 1 site in China.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This is a study to validate the effect of the intelligent diagnostic evidence-based analytic system in acute abdominal pain augmentation. Included physicians were randomly assigned into control or AI-assisted group. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Artificial Intelligence, Diagnoses Disease
What is being tested?
Artificial intelligence assistant system
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
151 participants
Where
1 siteChina
Study dates
15 Aug 2022to 1 Oct 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Males or females who are over 18 years old;
  • After qualified medical education and obtained the Certificate of medical practitioner;

Who cannot join

  • Physicians without qualified medical education and didn't obtain the Certificate of medical practitioner;
  • The researcher believes that the subjects are not suitable for participating in clinical trials.

Trial locations and contacts

1 site in 1 country.

China1 site
  • Renmin Hospital of Wuhan University

    Wuhan, Hubei, 430060

Other trials in China

About this study

Official title: Computer-aided, Evidence-based System Improved Clinical Diagnostic Accuracy of Certificated-Physicians in Acute Abdominal Pain

This is a study to validate the effect of the intelligent diagnostic evidence-based analytic system in acute abdominal pain augmentation. Included physicians were randomly assigned into control or AI-assisted group. In this experiment, the whole electronic health record of each acute abdominal pain patient was divided into two parts, signs and symptoms recording (including chief complaint, present history, physical examination, past medical history, trauma surgery history, personal history, family history, obstetrical history, menstrual history, blood transfusion history, drug allergy history) and auxiliary examination recording (including laboratory examination and radiology report). For each case, the control group readers will first read the signs and symptoms recording of electronic health record and make a clinical diagnosis. Then the readers have to decide to either order a list of auxiliary examinations or confirm the clinical diagnosis without further examination. If the readers choose to order examinations, the corresponding examination results will be feedback to the readers, and the readers can then decide to either continue to order a list of auxiliary examinations or make a confirming diagnosis. Such cycle will last until the reader make a confirming diagnosis. For the AI-assisted readers, the physicians were additionally provided with the feature extracted by IDEAS-AAP, a list of suspicious diagnoses predicted by IDEAS-AAP, and corresponding diagnostic criteria according to guidelines. After the readers get the examination results, the IDEAS-AAP will renew its diagnosis prediction

Read the detailed description

In recent years, with the continuous development of science and technology, the range of diagnostic tests and biomarkers for disease and treatment modalities has increased exponentially, and medical information has become increasingly complex. This requires the clinician to comprehensively evaluate the patient's condition, so as to choose the best examination and treatment. However, for the complex symptoms in the actual clinical environment, the corresponding diseases are numerous; In the face of complex and heavy clinical work, how to extract the important characteristics of patients' diseases faster and more accurately to achieve high-quality and accurate diagnosis and treatment is the key problem to be solved at present. For example, in the field of digestion, the chief complaint of abdominal pain is one of the most common clinical symptoms of patients seeking medical treatment, and some acute abdominal pain, such as gastrointestinal ulcer perforation, strangulated intestinal obstruction, acute obstructive suppurative cholangitis and other urgent onset, narrow treatment time window, high mortality. Clinicians must make a quick diagnosis and distinguish between those that require emergency intervention and those that do not in order to manage patients in a timely manner and avoid catastrophic events. However, the causes of abdominal pain are many and the mechanisms are complex. In addition, since pain is a subjective sensation and is greatly influenced by subjective factors, there are no clear objective indicators to determine whether or not and the degree of pain, and it is extremely challenging to correctly diagnose and interpret abdominal pain. To this end, the clinician must take a detailed history and perform a thorough physical examination when evaluating a patient's abdominal pain. In recent years, artificial intelligence technology has developed rapidly, especially in the field of medicine has been widely applied research, mainly reflected in the diagnosis and differential diagnosis of diseases, prognosis judgment and clinical decision analysis. Some studies have shown that in terms of auxiliary pathology and imaging diagnosis, AI has reached or even exceeded the average diagnostic level of corresponding specialists. Most of these studies focus on pattern recognition based on images, and the logical judgment based on natural language using medical records information is still in the preliminary development stage. There are no relevant reports on integrating comprehensive information of large medical records to make intelligent prediction of digestive tract diseases.

Being tested
Artificial intelligence assistant system

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Artificial intelligence assistant systemDevice

    The AI-assisted diagnosis system can provide the direction of disease diagnosis in real time and assist the doctor to give the final diagnosis

Study groups in NCT05497258
Study groupRoleWhat they receive
Experimental: with Artificial intelligence assistant systemExperimentalThe physicians were additionally provided with the feature extracted by the system, a list of suspicious diagnoses predicted by IDEAS-AAP, and corresponding diagnostic criteria according to guidelines. After the readers get the examination results, the IDEAS-AAP will renew its diagnosis prediction. IDEAS-AAP extracted feature from electronic health record, provided a list of suspicious diagnoses, and corresponding diagnostic criteria according to guidelines. After the readers get the examination results, the IDEAS-AAP will renew its diagnosis prediction.
Receives: Device: Artificial intelligence assistant system
No Intervention: without Artificial intelligence assistant systemNo interventionNot described

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The accuracy of clinical diagnosis.

    Calculation method = number of right cases / total number of cases 100%

    Measured: one week

Secondary outcomes (3)
  1. Accuracy of the prediction of disease based on whole electronic health record

    Calculation method = number of right cases / total number of cases 100%

    Measured: one week

  2. The prediction of disease based on whole electronic health record and criteria matching

    Calculation method = number of right cases / total number of cases 100%

    Measured: one week

  3. Time cost of EHR reading

    Measured: one week

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 Aug 2022
  2. Study start15 Aug 2022
  3. Primary completion1 Sep 2022
  4. Study completion1 Oct 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Diagnosis
Allocation
Randomised
Intervention model
Parallel groups
Model description
Experimental: doctor with AI-assisted system;Control:without AI-assisted system
Masking
None (open label)
Enrolment
151 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05497258
Sponsor's protocol ID
2022K-K146(C01)
Status last verified
Aug 2022
First submitted
9 Aug 2022
Last updated
8 Nov 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Artificial intelligence assistant system in people with Artificial Intelligence and Diagnoses Disease, run by Renmin Hospital of Wuhan University at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 8 Nov 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The accuracy of clinical diagnosis. (time frame: one week). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Nov 2022; AzTrials last refreshed its copy on 2 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in